BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Disruption of the auto-inhibitory intramolecular interactions due chromosome translocation leads to the formation of constitutively active chimeric BCR-ABL1 fusion oncoproteins that drives CML pathogenesis.